Sign In
Free Newsletter
NJ suspends doctor over medical marijuana approvals
New Jersey suspended a Bergen County doctor whom authorities accused of improperly approving medical marijuana for adults and minors.
BioMarin cuts 58 jobs at Amicus HQ in Princeton
The layoffs at Amicus Therapeutics’ Princeton headquarters follow BioMarin's recent $4.8 billion acquisition of the biotech.
Bristol Myers Squibb inks $15.2B drug deal with Hengrui
The partnership with Hengrui Pharma will develop 13 oncology, hematology and immunology drug programs worldwide.
RWJBarnabas expands care at Rahway hospital
A redesigned medical suite at Robert Wood Johnson University Hospital now includes cardiology, pulmonary and surgical services.
NJHA taps AI partnership to ease administrative burdens
The New Jersey Hospital Association is working with Jade Global to deploy technology aimed at improving hospital operations.
Serenium Therapy grows beyond Central Jersey to Bergen County (photos)
Serenium Therapy and Wellness opened a Hackensack office and plans new locations in Cherry Hill and Clifton.
New eating disorder treatment center opens in Princeton
A new eating disorder treatment center offering outpatient and partial hospital care for women is now open in Princeton.
AKCG acquires Hennes Communications, expands into Midwest
The fast-growing Glassboro-based firm is expanding its crisis PR services into Ohio while boosting its national media relations reach.
AtlantiCare, Stockton launch Atlantic City health college
Backed by a $15 million investment from the healthcare system, AtlantiCare and Stockton University will launch a health college in Atlantic City to expand training and workforce pipelines.
Amazon One Medical, HMH expand with 3rd NJ clinic
Amazon One Medical and Hackensack Meridian Health opened a third New Jersey clinic, in Englewood, expanding access to primary and virtual care services.
NJ hospital leaders react to spring 2026 safety grades
New Jersey hospital leaders respond to the latest report highlighting progress as well as continued quality focus statewide. See what they're saying.
Bayer to buy Perfuse Therapeutics for up to $2.45B
Bayer is planning a $2.45B acquisition of Perfuse Therapeutics to boost its ophthalmology pipeline with an eye disease treatment.
